secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2026-09-10T21:00:17+00:00
Accession:  0001213900-26-098847
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

iSpecimen gets Nasdaq extension to Nov 25, 2026 to regain equity compliance
---------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Sept 8, 2026; extension to Nov 25, 2026 to meet Rule 5550(b) minimum $2.5M stockholders' equity.
- Prior notice May 29, 2026; compliance plans submitted July 13, Aug 6, Sept 4, 2026.
- Private placement closed May 11, 2026 raised ~$2.5M; planned best-efforts public offering of ~$5M.
- Projected stockholders' equity ~$5.1M through June 30, 2027; delisting risk if not compliant by year-end 2026 report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000121390026098847/0001213900-26-098847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000121390026098847/ea0305069-8k_ispecimen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-098847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer